Cours Cocrystal Pharma Inc OTC Bulletin Board
Actions
US19188J1025
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 19,84 M 18,03 M |
---|---|---|---|---|---|
Résultat net 2024 * | -20 M -18,17 M | Résultat net 2025 * | -24 M -21,81 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-0,97
x | PER 2025 * |
-0,96
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 69,97% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 02/01/14 |
James Martin
CEO | Chief Executive Officer | 58 | 23/02/17 |
Roger Kornberg
CHM | Chairman | 77 | 02/01/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 02/01/14 |
Director/Board Member | 68 | 27/05/21 | |
Steven Rubin
BRD | Director/Board Member | 63 | 02/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,42% | 115 Md | |
+11,84% | 106 Md | |
-1,05% | 21,96 Md | |
-14,15% | 21,87 Md | |
-5,29% | 19,21 Md | |
-4,16% | 18,08 Md | |
-38,29% | 17,71 Md | |
+7,99% | 14,32 Md | |
+36,24% | 12,42 Md |